Bär & Karrer Advised the Selling Shareholders on the Sale of nspm and eluSCIdate to Cactus Life Sciences

Cactus Life Sciences, a leading global scientific communications agency, has acquired nspm and eluSCIdate, the largest medcomms firm in Switzerland (with offices in the UK), with a particular expertise in rare diseases.

Bär & Karrer advised the selling shareholders of nspm and eluSCIdate in this transaction. The team was led by Raphael Annasohn and further included Lukas Bründler, Luana Stämpfli, and Julian Lindt (all M&A), Daniel Bader, Martin Leu, Julian Hodel and Timon Hufschmid (all Tax), Laura Widmer and Luljeta Morina (both Employment), Mani Reinert and Tim Meyer (both Antitrust), Rehana Harasgama (Data Protection), as well as Jonas Bornhauser (IP/IT).